ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 188 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $793,000 | -51.6% | 23,056 | -59.4% | 0.02% | -45.0% |
| Q4 2016 | $1,639,000 | +173.2% | 56,829 | +201.1% | 0.04% | +185.7% |
| Q3 2016 | $600,000 | -41.5% | 18,872 | -40.2% | 0.01% | -33.3% |
| Q2 2016 | $1,025,000 | +105.4% | 31,576 | +125.6% | 0.02% | +162.5% |
| Q4 2015 | $499,000 | +89.7% | 13,995 | +75.9% | 0.01% | +100.0% |
| Q3 2015 | $263,000 | -57.2% | 7,956 | -45.7% | 0.00% | -63.6% |
| Q2 2015 | $614,000 | +137.1% | 14,659 | +79.6% | 0.01% | +175.0% |
| Q4 2014 | $259,000 | -77.0% | 8,160 | -82.1% | 0.00% | -81.8% |
| Q3 2014 | $1,127,000 | +145.0% | 45,537 | +123.5% | 0.02% | +214.3% |
| Q2 2014 | $460,000 | +46.5% | 20,379 | +61.9% | 0.01% | +133.3% |
| Q4 2013 | $314,000 | +2.6% | 12,589 | +12.8% | 0.00% | -25.0% |
| Q3 2013 | $306,000 | – | 11,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |